What is the recommended evaluation and management for a pustular rash on the scalp?

Pustular Rash on the Scalp: Evaluation and Management

A pustular rash on the scalp most likely represents either inflammatory tinea capitis (fungal infection) or erosive pustular dermatosis (EPD), and you must immediately obtain scalp scrapings/hair plucks for fungal culture to guide definitive treatment, while initiating empiric oral antifungal therapy if cardinal signs (scale, lymphadenopathy, alopecia) are present.

Initial Diagnostic Approach

Key Clinical Features to Identify

For Tinea Capitis (Fungal Infection):

• Look for patchy alopecia with pustules and low-grade folliculitis
• Check for painful regional lymphadenopathy 1
• Examine for scale, broken hair stubs ("black dot" appearance), or boggy inflammatory masses (kerion) studded with pustules 1
• Most common in preadolescent children, though can occur in immunocompromised adults 1

For Erosive Pustular Dermatosis:

• Typically affects elderly patients (mean age ~59 years) 2
• Look for chronic erosive plaques with pustules leading to scarring alopecia 3
• Check for predisposing factors: androgenetic alopecia, actinic damage, recent trauma 2, 4
• Absence of follicular ostia with skin atrophy on examination 2

Mandatory Diagnostic Testing

Obtain scalp specimens immediately via scalpel scraping, hair pluck, brush, or swab for microscopy and culture 1. This is critical because:

• Treatment choice depends entirely on the causative organism
• Tinea capitis requires organism-specific oral antifungals
• EPD is a diagnosis of exclusion requiring biopsy to rule out malignancy, infection, and autoimmune conditions 4

Treatment Algorithm

If Tinea Capitis is Suspected (Especially in Children/Young Adults)

Start treatment empirically if cardinal signs present (scale, lymphadenopathy, alopecia) while awaiting culture results 1. Topical therapy alone is inadequate—oral therapy is mandatory 1.

First-Line Oral Antifungal Selection:

For Trichophyton species (T. tonsurans, T. violaceum—most common in UK/urban areas):

• Terbinafine is superior 1
  • <20 kg: 62.5 mg daily for 2-4 weeks
  • 20-40 kg: 125 mg daily for 2-4 weeks

  • 40 kg: 250 mg daily for 2-4 weeks

For Microsporum species (M. canis—still common in Europe):

• Griseofulvin is superior 1
  • <50 kg: 15-20 mg/kg/day for 6-8 weeks

  • 50 kg: 1 g daily for 6-8 weeks

Critical Pitfall: Terbinafine fails against Microsporum because it cannot reach the scalp surface where arthroconidia are located in prepubertal children 1. Using the wrong drug for the wrong organism leads to treatment failure.

If Treatment Fails:

• First assess compliance, drug absorption, and reinfection 1
• If clinical improvement but positive mycology persists: continue current therapy 2-4 more weeks
• If no clinical improvement: switch to itraconazole (5 mg/kg/day) as second-line 1

If Erosive Pustular Dermatosis is Suspected (Especially in Elderly)

Biopsy is mandatory to exclude malignancy, infection, vesiculobullous disease, and other inflammatory conditions 4. EPD is a diagnosis of exclusion.

First-Line Treatment:

High-potency topical corticosteroids (e.g., clobetasol propionate) are the primary treatment 3, 2, 4:

• Apply daily to affected areas
• Expect reduction in inflammatory signs within weeks 2
• Major limitation: Recurrence after withdrawal is common 4

Consider adding oral zinc for enhanced efficacy 3

Maintenance/Second-Line Options:

Topical tacrolimus 0.1% is highly effective for maintenance and avoiding steroid atrophy 3, 2, 4:

• All patients in one series showed reduction of inflammatory signs 2
• Valuable for long-term management without skin atrophy risk 5

Alternative second-line options (based on emerging evidence):

• Topical dapsone 5% gel: rapid improvement in refractory cases 6
• Curettage-assisted aminolevulinic acid-photodynamic therapy 4
• Systemic retinoids for severe/refractory disease 4

Critical Management Point:

Address scalp hygiene aggressively, especially if thick adherent crusts present 7:

• Regular cleansing with dilute sodium hypochlorite compresses
• Combination with topical corticosteroids and antibiotics
• Poor scalp hygiene significantly worsens outcomes and increases recurrence 7

Refractory cases respond better to combination therapy than monotherapy 8

Key Clinical Pitfalls

1. Misdiagnosing kerion as bacterial abscess: Kerion is a sterile inflammatory response to dermatophytes, not bacterial infection, though secondary infection can occur 1

2. Using topical therapy alone for tinea capitis: This will fail—oral therapy is mandatory for cure 1

3. Wrong antifungal for wrong organism: Terbinafine fails for Microsporum; griseofulvin requires longer courses (12-18 weeks) for Trichophyton 1

4. Stopping EPD treatment too early: Maintenance therapy with tacrolimus is essential to prevent recurrence 3, 4

5. Missing underlying malignancy in elderly patients: Always biopsy suspected EPD to exclude non-melanoma skin cancer 9